Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Yang, Ya ^a   Rhodus, Nelson L ^b   Ondrey, Frank G ^c   Wuertz, Beverly R K ^c   Chen, Xiaobing ^d   Zhu, Yaqin ^a   Griffin, Timothy J ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TUMOR MARKER;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOPSY; CANCER CELL; CANCER GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFICACY; HUMAN; HUMAN TISSUE; MOUTH CANCER; MOUTH EXAMINATION; MOUTH SQUAMOUS CELL CARCINOMA; ORAL BRUSH BIOPSY; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEOMICS; VALIDITY; WESTERN BLOTTING; GENETICS; METABOLISM; MOUTH TUMOR; REPORTER GENE; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

BIOPSY; GENES, REPORTER; HUMANS; MOUTH NEOPLASMS; PROTEOMICS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84899687526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095389     Document Type: Article

References (38)

1. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, et al. (2012) SEER Cancer Statistics Review, 1975-2010. National Cancer Institute.
2. Rhodus NL (2005) Oral cancer: leukoplakia and squamous cell carcinoma. Dent Clin North Am 49: 143-165, ix.
3. Silverman S Jr (2001) Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 132 Suppl: 7S-11S.
4. Rhodus NL (2009) Oral cancer and precancer: improving outcomes. Compend Contin Educ Dent 30: 486-488, 490-484, 496-488 passim; quiz 504, 520.
5. Lingen MW, Kalmar JR, Karrison T, Speight PM (2008) Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 44: 10-22. (Pubitemid 350258631)
6. Axell T, Pindborg JJ, Smith CJ, van der Waal I (1996) Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 25: 49-54.
7. Lumerman H, Freedman P, Kerpel S (1995) Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79: 321-329.
8. Holmstrup P, Vedtofte P, Reibel J, Stoltze K (2007) Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med 36: 262-266. (Pubitemid 46632607)
9. Pentenero M, Carrozzo M, Pagano M, Galliano D, Broccoletti R, et al. (2003) Oral mucosal dysplastic lesions and early squamous cell carcinomas: underdiagnosis from incisional biopsy. Oral Dis 9: 68-72. (Pubitemid 36460017)
10. Mercadante V, Paderni C, Campisi G (2012) Novel non-invasive adjunctive techniques for early oral cancer diagnosis and oral lesions examination. Curr Pharm Des 18: 5442-5451.
11. Acha A, Ruesga MT, Rodriguez MJ, Martinez de Pancorbo MA, Aguirre JM (2005) Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer. Med Oral Patol Oral Cir Bucal 10: 95-102. (Pubitemid 40516479)
12. Mehrotra R, Gupta A, Singh M, Ibrahim R (2006) Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer 5: 11.
13. Driemel O (2007) Protein profiling of oral brush biopsies: S100A8 and S100A9 can differentiate between normal, premalignant, and tumor cells. Proteomics Clin Appl 1: 486-493.
14. Remmerbach TW, Maurer K, Janke S, Schellenberger W, Eschrich K, et al. (2011) Oral brush biopsy analysis by matrix assisted laser desorption/ ionisation-time of flight mass spectrometry profiling-a pilot study. Oral Oncol 47: 278-281.
15. Zhang Y, Fonslow BR, Shan B, Baek MC, Yates JR 3rd (2013) Protein analysis by shotgun/bottom-up proteomics. Chem Rev 113: 2343-2394.
16. Sacks PG (1996) Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev 15: 27-51.
17. Rhim JS (1989) Neoplastic transformation of human epithelial cells in vitro. Anticancer Res 9: 1345-1365.
18. Wu JZ, Adachi I, Watanabe T (1991) Cytotoxic activity of FK973 against human oral and breast cancer cells. Chin Med J (Engl) 104: 834-837.
19. Wisniewski JR, Zougman A, Nagaraj N, Mann M (2009) Universal sample preparation method for proteome analysis. Nat Methods 6: 359-362.
20. Yang F, Shen Y, Camp DG 2nd, Smith RD (2012) High-pH reversed-phase chromatography with fraction concatenation for 2D proteomic analysis. Expert Rev Proteomics 9: 129-134.
21. Olsen JV, Schwartz JC, Griep-Raming J, Nielsen ML, Damoc E, et al. (2009) A dual pressure linear ion trap Orbitrap instrument with very high sequencing speed. Mol Cell Proteomics 8: 2759-2769.
22. Onsongo G, Stone MD, Van Riper SK, Chilton J, Wu B, et al. (2010) LTQ-iQuant: A freely available software pipeline for automated and accurate protein quantification of isobaric tagged peptide data from LTQ instruments. Proteomics 10: 3533-3538.
23. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, et al. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169.
24. Ting L, Rad R, Gygi SP, Haas W (2011) MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics. Nat Methods 8: 937-940.
25. Wenger CD, Lee MV, Hebert AS, McAlister GC, Phanstiel DH, et al. (2011) Gas-phase purification enables accurate, multiplexed proteome quantification with isobaric tagging. Nat Methods 8: 933-935.
26. Wen J, Nikitakis NG, Chaisuparat R, Greenwell-Wild T, Gliozzi M, et al. (2011) Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma. Am J Pathol 178: 2866-2878.
27. Gumus ZH, Du B, Kacker A, Boyle JO, Bocker JM, et al. (2008) Effects of tobacco smoke on gene expression and cellular pathways in a cellular model of oral leukoplakia. Cancer Prev Res (Phila) 1: 100-111.
28. Gamou S, Shimizu N (1987) Change in metabolic turnover is an alternate mechanism increasing cell surface epidermal growth factor receptor levels in tumor cells. J Biol Chem 262: 6708-6713.
29. Duffey DC, Chen Z, Dong G, Ondrey FG, Wolf JS, et al. (1999) Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 59: 3468-3474. (Pubitemid 29334510)
30. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, et al. (2009) Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 45: 324-334.
31. Patel A, Miller L, Ahmed K, Ondrey F (2004) NF-Kappa-B downregulation strategies in head and neck cancer treatment. Otolaryngol Head Neck Surg 131: 288-295. (Pubitemid 39208708)
32. Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, et al. (2005) Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J Exp Med 202: 1659-1668. (Pubitemid 41815872)
33. Wang N, Thuraisingam T, Fallavollita L, Ding A, Radzioch D, et al. (2006) The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response. Cancer Res 66: 3062-3070.
34. Caicedo-Granados EE, Wuertz BR, Marker PH, Lee GS, Ondrey FG (2011) The effect of indomethacin on paclitaxel sensitivity and apoptosis in oral squamous carcinoma cells: the role of nuclear factor-kappaB inhibition. Arch Otolaryngol Head Neck Surg 137: 799-805.
35. Scott A, Weldon S, Taggart CC (2011) SLPI and elafin: multifunctional antiproteases of the WFDC family. Biochem Soc Trans 39: 1437-1440.
36. Taggart CC, Greene CM, McElvaney NG, O'Neill S (2002) Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination. J Biol Chem 277: 33648-33653.
37. Quabius ES, Moller P, Haag J, Pfannenschmidt S, Hedderich J, et al. (2013) The role of the antileukoprotease SLPI in smoking-induced human papillomavirusindependent head and neck squamous cell carcinomas. Int J Cancer.
38. Vizcaino JA, Cote RG, Csordas A, Dianes JA, Fabregat A, et al. (2013) The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res 41: D1063-1069.